A Phase 2b, Single-Arm, Open-Label, Multicenter Study of the Safety of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Study Summary

This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.

Interventions

Study Locations

Facility	City	State	Country
Center for Inherited Blood Disorders	Orange	California	United States
University of California San Francisco	San Francisco	California	United States
Kaiser Permanente	Vallejo	California	United States

Official Trial Information

View on ClinicalTrials.gov